© 2020 MJH Life Sciences and Urology Times. All rights reserved.
© 2020 MJH Life Sciences™ and Urology Times. All rights reserved.
September 11, 2020
Updated results were also reported on other key end points, including time to pain progression, first symptomatic skeletal event, and initiation of chemotherapy.
September 10, 2020
Combination approach could overcome mechanisms that previously led to poor outcomes with single-agent checkpoint inhibition.
September 09, 2020
A new analysis supports return to widespread screening.
September 08, 2020
The results suggest the minimally-invasive procedure is an acceptable alternative to immediate surgery or radiation.